Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Efficacy and Safety of Liraglutide Compared to Sitagliptin, Both in Combination With Metformin in Chinese Subjects With Type 2 Diabetes.(LIRA-DPP-4 CHINA™)

NCT02008682 is registered in ClinicalTrials.gov with Novo Nordisk A/S as lead sponsor.

NCT NCT02008682
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02008682 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Efficacy and Safety of Liraglutide Compared to Sitagliptin, Both in Combination With Metformin in Chinese Subjects With Type 2 Diabetes.(LIRA-DPP-4 CHINA™)
Lead sponsor
Novo Nordisk A/S
Phase
Phase 4
Overall status
Completed
Start date
December 31, 2013
Completion date
November 30, 2014
Enrollment
368 (actual)
Sites
25

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes, diabetes mellitus, type 2